Application of delayed extraction-matrix-assisted laser desorption ionization time-of-fight mass spectrometry for analysis of sphingolipids in pericardial fluid, peritoneal fluid and serum from Gaucher disease patients

被引:25
作者
Fujiwaki, T
Yamaguchi, S
Tasaka, M
Sakura, N
Taketomi, T
机构
[1] Shimane Med Univ, Dept Pediat, Izumo, Shimane 6938501, Japan
[2] Hiroshima Univ, Sch Med, Dept Pediat, Minami Ku, Hiroshima 7348551, Japan
[3] Shinshu Univ, Sch Med, Res Ctr Aging & Adaptat, Dept Biochem, Matsumoto, Nagano 3908621, Japan
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2002年 / 776卷 / 01期
关键词
sphingolipids;
D O I
10.1016/S1570-0232(02)00177-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Gaucher disease is a glycolipid storage disorder characterized by the accumulation of glucosylceramide. Using delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry (DE-MALDI-TOF-MS), we analyzed sphingolipids in pericardial fluid, peritoneal fluid, and serum from two patients with Gaucher disease. Crude lipids were extracted from 1 ml each of pericardial fluid, peritoneal fluid, and serum with chloroform and methanol. After mild alkaline treatment of the crude lipids, a sphingolipid fraction was prepared and analyzed by DE-MALDI-TOF-MS. The results were as follows: (a) in all the specimens, peaks of ceramide monohexoside and sphingomyelin were detected in both the controls and Gaucher disease patients; (b) in pericardial fluid, peritoneal fluid, and serum, the ceramide monohexoside/sphingomyelin ratio was increased in the Gaucher disease patients compared with in the controls. It was indicated that the accumulation of ceramide monohexoside in such samples from Gaucher disease patients can be easily detected with this DE-MALDI-TOF-MS method. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:115 / 123
页数:9
相关论文
共 28 条
[1]  
Adachi Y, 1998, ACTA PAEDIATR JAPON, V40, P374
[2]   CONSTRICTIVE PERICARDITIS IN GAUCHERS DISEASE [J].
BENBASSA.J ;
BASSAN, H ;
MILWIDSK.H ;
SACKS, M ;
GROEN, JJ .
AMERICAN JOURNAL OF MEDICINE, 1968, 44 (04) :647-&
[3]  
Beutler E., 1995, METABOLIC MOL BASES, P2641
[4]  
COSTELLO CE, 1994, PROG BRAIN RES, V101, P45
[5]   NEONATAL ASCITES DUE TO LYSOSOMAL STORAGE DISEASE [J].
DANEMAN, A ;
STRINGER, D ;
REILLY, BJ .
RADIOLOGY, 1983, 149 (02) :463-467
[6]   BLOOD GLUCOSYLCERAMIDE LEVELS IN GAUCHERS-DISEASE AND ITS DISTRIBUTION AMONGST LIPOPROTEIN FRACTIONS [J].
DAWSON, G ;
OH, JY .
CLINICA CHIMICA ACTA, 1977, 75 (01) :149-153
[7]   THE USE OF FAST-ATOM-BOMBARDMENT AND LASER DESORPTION MASS-SPECTROMETRY IN THE ANALYSIS OF COMPLEX CARBOHYDRATES [J].
EGGE, H ;
PETERKATALINIC, J ;
KARAS, M ;
STAHL, B .
PURE AND APPLIED CHEMISTRY, 1991, 63 (04) :491-498
[8]   Application of delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry for analysis of sphingolipids in tissues from sphingolipidosis patients [J].
Fujiwaki, T ;
Yamaguchi, S ;
Sukegawa, K ;
Taketomi, T .
JOURNAL OF CHROMATOGRAPHY B, 1999, 731 (01) :45-52
[9]  
FUJIWAKI T, UNPUB BRAIN DEV
[10]   CONGENITAL ASCITES AS A PRESENTING SIGN OF LYSOSOMAL STORAGE DISEASE [J].
GILLAN, JE ;
LOWDEN, JA ;
GASKIN, K ;
CUTZ, E .
JOURNAL OF PEDIATRICS, 1984, 104 (02) :225-231